Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
Wright Medical Group N.V. (WMGI)
|
Add to portfolio |
|
|
|
| Price: |
$30.59
| | Metrics |
| OS: |
129.9
|
M
| |
-13
|
% ROE
|
| Market cap: |
$3.97
|
B
| |
|
% ROIC
|
|
Net debt:
|
$1.22
|
B
| |
14.4
|
x Debt/EBITDA
|
|
EV:
|
$5.2
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$84.8
|
M
| |
61.3
|
x EV/EBITDA
|
|
EBIT
|
($11.5)
|
M
| |
|
|
| EPS |
($0.69)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-29-19 | Dec-30-18 | Dec-31-17 | Dec-25-16 | Dec-27-15 | Dec-31-14 | Dec-31-13 | Dec-30-12 |
| Revenues | 920.9 | 836.2 | 745.0 | 690.4 | 405.3 | 298.0 | 242.3 | 277.5 |
| Revenue growth | 10.1% | 12.2% | 7.9% | 70.3% | 36.0% | 23.0% | -12.7% | 6.3% |
| Cost of goods sold | 188.6 | 180.2 | 160.9 | 192.4 | 113.6 | 73.2 | 59.7 | 81.9 |
| Gross profit | 732.3 | 656.0 | 584.0 | 498.0 | 291.7 | 224.8 | 182.6 | 195.6 |
| Gross margin | 79.5% | 78.5% | 78.4% | 72.1% | 72.0% | 75.4% | 75.4% | 70.5% |
| Selling, general and administrative | 614.7 | 578.0 | 525.2 | 541.6 | 424.4 | 289.6 | 230.8 | 170.4 |
| Research and development | 74.1 | 59.1 | 50.1 | 50.5 | 39.3 | 25.0 | 20.3 | 22.5 |
| EBITA | 43.5 | 18.9 | 8.7 | -94.1 | -172.0 | -89.8 | -68.5 | 3.4 |
| EBITA margin | 4.7% | 2.3% | 1.2% | -13.6% | -42.4% | -30.1% | -28.3% | 1.2% |
| Amortization of intangibles | 31.9 | 26.7 | 28.4 | 28.8 | 16.8 | 10.0 | 7.5 | 11.7 |
| EBIT | 11.6 | -7.8 | -19.7 | -123.0 | -188.8 | -99.8 | -76.0 | -8.4 |
| EBIT margin | 1.3% | -0.9% | -2.6% | -17.8% | -46.6% | -33.5% | -31.3% | -3.0% |
| Pre-tax income | -79.2 | -169.8 | -99.9 | -178.3 | -241.0 | -246.8 | -230.4 | -32.7 |
| Income taxes | 13.0 | -0.5 | -35.0 | -13.4 | -3.7 | -6.3 | 49.8 | -10.9 |
| Tax rate | | 0.3% | 35.0% | 7.5% | 1.5% | 2.6% | | 33.5% |
| Net income | -114.2 | -169.5 | -202.6 | -432.4 | -298.7 | -259.7 | -273.9 | -21.7 |
| Net margin | -12.4% | -20.3% | -27.2% | -62.6% | -73.7% | -87.1% | -113.0% | -7.8% |
| |
| Diluted EPS | ($0.73) | ($1.50) | ($0.62) | ($1.60) | ($3.66) | ($4.69) | ($5.82) | ($0.54) |
| Shares outstanding (diluted) | 126.6 | 112.6 | 104.5 | 103.0 | 64.8 | 51.3 | 48.1 | 40.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|